Clinical Trial Update: Imaging Immune Activation in COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating imaging-based immune activation in COVID-19 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome

Snippet

Sponsor: CellSight Technologies, Inc. | Conditions: Covid19, SARS-CoV Infection | Phase 2 | Status: RECRUITING